Burning Rock Biotech Ltd (BNR) is down Friday morning, with the stock falling -4.88% in pre-market trading to 1.17.
BNR's short-term technical score of 24 indicates that the stock has traded less bullishly over the last month than 76% of stocks on the market. In the Diagnostics & Research industry, which ranks 134 out of 146 industries, the stock ranks higher than 41% of stocks.
Burning Rock Biotech Ltd has fallen 21.15% over the past month, closing at $1.58 on August 11. During this period of time, the stock fell as low as $1.21 and as high as $1.61. BNR has an average analyst recommendation of Strong Buy. The company has an average price target of $7.30.
BNR has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on BNR!
Burning Rock Biotech Ltd has a Long-Term Technical rank of 3. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 97% of the market scoring higher. In the Diagnostics & Research industry which is number 130 by this metric, BNR ranks better than 130% of stocks.
